Item 5.07. Submission of Matters to a Vote of Security Holders.
We held our 2021 Annual Meeting of Stockholders onDecember 16, 2020 , at which three proposals were submitted to, and approved by, our stockholders. The holders of 20,130,152 shares of our common stock were present or represented by proxy at the meeting. The proposals are described in detail in our definitive proxy statement for the 2021 Annual Meeting filed with theSecurities and Exchange Commission onNovember 2, 2020 . The final results for the votes for each proposal are set forth below. At the annual meeting, each ofWilliam Aliski andAnne VanLent was elected as a Class I Director ofApplied Genetic Technologies Corporation (the "Company"), to serve a three-year term expiring at the 2024 Annual Meeting of Stockholders. The votes cast in the election of the directors were as follows: Broker Nominee Votes For Votes Withheld Non-Votes William Aliski 13,807,271 448,071 5,874,810 Anne VanLent 13,819,180 436,162 5,874,810 At the annual meeting, our stockholders approved, on an advisory basis, the compensation paid to our named executive officers. The votes cast on this proposal were as follows: Broker Proposal Votes For Votes Against Abstentions Non-Votes To approve, on an advisory basis, the compensation paid to our named executive officers 14,006,205 161,767
87,370 5,874,810
At the annual meeting, our stockholders also approved the proposal to ratify the appointment ofErnst & Young LLP as our independent registered public accounting firm for our fiscal year endingJune 30, 2021 . The votes cast on this proposal were as follows: Broker Proposal Votes For Votes Against Abstentions Non-Votes To ratify the appointment ofErnst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2021 19,829,407 42,444 258,301 - 2
--------------------------------------------------------------------------------
© Edgar Online, source